Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 4
1974 3
1975 15
1976 20
1977 26
1978 55
1979 31
1980 36
1981 26
1982 29
1983 32
1984 27
1985 40
1986 38
1987 24
1988 13
1989 32
1990 35
1991 41
1992 31
1993 44
1994 28
1995 31
1996 30
1997 19
1998 33
1999 16
2000 25
2001 16
2002 10
2003 29
2004 18
2005 20
2006 17
2007 15
2008 14
2009 20
2010 18
2011 24
2012 32
2013 22
2014 24
2015 21
2016 28
2017 34
2018 35
2019 45
2020 41
2021 55
2022 37
2023 34
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,336 results

Results by year

Filters applied: . Clear all
Page 1
Adenosine deaminase deficiency: a review.
Flinn AM, Gennery AR. Flinn AM, et al. Orphanet J Rare Dis. 2018 Apr 24;13(1):65. doi: 10.1186/s13023-018-0807-5. Orphanet J Rare Dis. 2018. PMID: 29690908 Free PMC article. Review.
Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID).
Secord E, Hartog NL. Secord E, et al. Ther Clin Risk Manag. 2022 Sep 22;18:939-944. doi: 10.2147/TCRM.S350762. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 36172599 Free PMC article. Review.
Adenosine deaminase deficiency (ADA) is a purine salvage pathway deficiency that results in buildup of toxic metabolites causing death in rapidly dividing cells, especially lymphocytes. ...
Adenosine deaminase deficiency (ADA) is a purine salvage pathway deficiency that results in buildup of toxic metabolite …
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
Kohn DB, Booth C, Shaw KL, Xu-Bayford J, Garabedian E, Trevisan V, Carbonaro-Sarracino DA, Soni K, Terrazas D, Snell K, Ikeda A, Leon-Rico D, Moore TB, Buckland KF, Shah AJ, Gilmour KC, De Oliveira S, Rivat C, Crooks GM, Izotova N, Tse J, Adams S, Shupien S, Ricketts H, Davila A, Uzowuru C, Icreverzi A, Barman P, Campo Fernandez B, Hollis RP, Coronel M, Yu A, Chun KM, Casas CE, Zhang R, Arduini S, Lynn F, Kudari M, Spezzi A, Zahn M, Heimke R, Labik I, Parrott R, Buckley RH, Reeves L, Cornetta K, Sokolic R, Hershfield M, Schmidt M, Candotti F, Malech HL, Thrasher AJ, Gaspar HB. Kohn DB, et al. N Engl J Med. 2021 May 27;384(21):2002-2013. doi: 10.1056/NEJMoa2027675. Epub 2021 May 11. N Engl J Med. 2021. PMID: 33974366 Free PMC article. Clinical Trial.
Updated Management Guidelines for Adenosine Deaminase Deficiency.
Grunebaum E, Booth C, Cuvelier GDE, Loves R, Aiuti A, Kohn DB. Grunebaum E, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1665-1675. doi: 10.1016/j.jaip.2023.01.032. Epub 2023 Feb 1. J Allergy Clin Immunol Pract. 2023. PMID: 36736952
Gene therapy for adenosine deaminase severe combined immune deficiency-An unexpected journey of four decades.
Kohn DB. Kohn DB. Immunol Rev. 2024 Mar;322(1):148-156. doi: 10.1111/imr.13293. Epub 2023 Nov 30. Immunol Rev. 2024. PMID: 38033164 Review.
Severe combined immune deficiency due to adenosine deaminase deficiency (ADA SCID) is an inborn error of immunity with pan-lymphopenia, due to accumulated cytotoxic adenine metabolites. ...
Severe combined immune deficiency due to adenosine deaminase deficiency (ADA SCID) is an inborn error of immunity with …
1,336 results